Theratechnologies Inc
TSX:TH

Watchlist Manager
Theratechnologies Inc Logo
Theratechnologies Inc
TSX:TH
Watchlist
Price: 4.47 CAD -4.89%
Market Cap: 205.5m CAD

Relative Value

The Relative Value of one TH stock under the Base Case scenario is 5.76 CAD. Compared to the current market price of 4.47 CAD, Theratechnologies Inc is Undervalued by 22%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TH Relative Value
Base Case
5.76 CAD
Undervaluation 22%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
41
vs Industry
87
Median 3Y
1
Median 5Y
1.7
Industry
7.9
Forward
1.8
vs History
vs Industry
Median 3Y
-8.1
Median 5Y
-16.1
Industry
24
Forward
-44.9
vs History
4
vs Industry
6
Median 3Y
-6.2
Median 5Y
-23.7
Industry
21.6
vs History
vs Industry
Median 3Y
-3.2
Median 5Y
-6.3
Industry
23.7
vs History
vs Industry
Median 3Y
-2.9
Median 5Y
-2.8
Industry
3.4
vs History
41
vs Industry
73
Median 3Y
1.1
Median 5Y
2.1
Industry
8.3
Forward
2.1
vs History
41
vs Industry
73
Median 3Y
1.5
Median 5Y
2.7
Industry
10.3
vs History
0
vs Industry
12
Median 3Y
4.5
Median 5Y
-6.4
Industry
6.7
Forward
14.5
vs History
0
vs Industry
10
Median 3Y
5.9
Median 5Y
-4.4
Industry
7.2
Forward
57.9
vs History
4
vs Industry
4
Median 3Y
-6.3
Median 5Y
-31
Industry
8.2
vs History
vs Industry
1
Median 3Y
-11.5
Median 5Y
-49.3
Industry
6.7
vs History
47
vs Industry
28
Median 3Y
8.6
Median 5Y
9.7
Industry
5.7

Multiples Across Competitors

TH Competitors Multiples
Theratechnologies Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Theratechnologies Inc
TSX:TH
205.5m CAD 1.8 -16.3 17.2 21.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 924 975 -161 240.4 -195 797.2 -193 563
US
Abbvie Inc
NYSE:ABBV
395.1B USD 6.6 168.4 16.3 23.1
US
Amgen Inc
NASDAQ:AMGN
171.7B USD 4.8 24.5 17.8 17.8
US
Gilead Sciences Inc
NASDAQ:GILD
153.3B USD 5.3 18.9 12.7 12.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.7B USD 9.6 30.7 22.5 23.5
US
Epizyme Inc
F:EPE
94.1B EUR 2 076.6 -529.9 -577 -561.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.5B USD 5.4 17 16.1 18.2
AU
CSL Ltd
ASX:CSL
86.6B AUD 3.7 19.3 13 16.2
NL
argenx SE
XBRU:ARGX
46.7B EUR 15.1 35.6 61.6 63.3
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
53.6B USD 16.7 1 230.6 161.8 196.2
P/E Multiple
Earnings Growth PEG
CA
Theratechnologies Inc
TSX:TH
Average P/E: 193.1
Negative Multiple: -16.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -161 240.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
168.4
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
24.5
45%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
18.9
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
30.7
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -529.9 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17
9%
1.9
AU
CSL Ltd
ASX:CSL
19.3
11%
1.8
NL
argenx SE
XBRU:ARGX
35.6
40%
0.9
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 230.6
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
Theratechnologies Inc
TSX:TH
Average EV/EBITDA: 37.7
17.2
47%
0.4
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 797.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.3
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
17.8
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.7
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.5
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -577 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.1
11%
1.5
AU
CSL Ltd
ASX:CSL
13
8%
1.6
NL
argenx SE
XBRU:ARGX
61.6
807%
0.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
161.8
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
Theratechnologies Inc
TSX:TH
Average EV/EBIT: 43.6
21.1
37%
0.6
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -193 563 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.1
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
17.8
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.7
12%
1.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.5
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -561.6 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.2
13%
1.4
AU
CSL Ltd
ASX:CSL
16.2
11%
1.5
NL
argenx SE
XBRU:ARGX
63.3
N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
196.2
N/A N/A